UNVEILING NOVEL BIOMARKERS FOR EARLY DISEASE DETECTION

Early recognition of diseases is crucial for improving patient outcomes and reducing the burden of chronic conditions. Traditionally, disease assessment has relied on symptomatic observations and destructive diagnostic tests. However, these approaches often fail to detect diseases in their preclinical stages, when intervention is highly effective.